Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana Taylor

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Health & Drug Benefits|March 26, 2016
All-Oral Regimen May Become a New Standard of Care in Advanced Multiple MyelomaDana Taylor
American Health & Drug Benefits|March 26, 2016
Consistent Benefit Over Time in Elotuzumab StudiesDana Taylor
American Health & Drug Benefits|March 26, 2016
Multiple Myeloma Therapy in 2015: "An Extraordinary Moment in Oncology"Dana Taylor
The American Surgeon|November 21, 2024
Outcomes After Duodenoduodenostomy for Superior Mesenteric Artery SyndromeDarwin Ang, Alana Hofmann, Abdelrahman Attili, et al.
The American Surgeon|November 2, 2020
Statewide Seasonal Variations of Infections Within the Intensive Care Unit Among the Trauma PopulationJason M Clark, Hamza Durrani, Josh D Hagan, et al.
The American Surgeon|October 14, 2021
The Statewide Epidemiology of Mucormycosis Among Trauma Patients in FloridaJason Michael Clark, Huazhi Liu, Susan Collins, et al.
The American Surgeon|August 20, 2020
An Early Case of Fat Embolism Syndrome Occurring Following PolytraumaJanelle-Cheri A Millen, Carrie Watson, John M Cain, et al.
The American Surgeon|December 15, 2021
Frailty Score as a Predictor of Outcomes in Geriatric Patients with Isolated Hip FracturesWhiyie A Sang, Hamza Durrani, Huazhi Liu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Health & Drug Benefits|March 26, 2016
All-Oral Regimen May Become a New Standard of Care in Advanced Multiple MyelomaDana Taylor
American Health & Drug Benefits|March 26, 2016
Consistent Benefit Over Time in Elotuzumab StudiesDana Taylor
American Health & Drug Benefits|March 26, 2016
Multiple Myeloma Therapy in 2015: "An Extraordinary Moment in Oncology"Dana Taylor
The American Surgeon|November 21, 2024
Outcomes After Duodenoduodenostomy for Superior Mesenteric Artery SyndromeDarwin Ang, Alana Hofmann, Abdelrahman Attili, et al.
The American Surgeon|November 2, 2020
Statewide Seasonal Variations of Infections Within the Intensive Care Unit Among the Trauma PopulationJason M Clark, Hamza Durrani, Josh D Hagan, et al.
The American Surgeon|October 14, 2021
The Statewide Epidemiology of Mucormycosis Among Trauma Patients in FloridaJason Michael Clark, Huazhi Liu, Susan Collins, et al.
The American Surgeon|August 20, 2020
An Early Case of Fat Embolism Syndrome Occurring Following PolytraumaJanelle-Cheri A Millen, Carrie Watson, John M Cain, et al.
The American Surgeon|December 15, 2021
Frailty Score as a Predictor of Outcomes in Geriatric Patients with Isolated Hip FracturesWhiyie A Sang, Hamza Durrani, Huazhi Liu, et al.
Pageof 1